Response Predictors to Calcineurin Inhibitors in Patients with Primary Membranous Nephropathy

Conclusions: Serum SAA1 may be a candidate PMN biomarker that can be used to discriminate CNI NR cases from remission patients. The combination of SAA1 and the PLA2R antibody increases the accuracy of diagnosis.Am J Nephrol 2018;47:266 –274
Source: American Journal of Nephrology - Category: Neurology Source Type: research